Improved Survival in Down Syndrome over the Last 60 Years and the Impact of Perinatal Factors in Recent Decades

被引:58
|
作者
Glasson, Emma J. [1 ]
Jacques, Angela [1 ]
Wong, Kingsley [1 ]
Bourke, Jenny [1 ]
Leonard, Helen [1 ]
机构
[1] Univ Western Australia, Telethon Kids Inst, POB 855, Perth, WA 6872, Australia
来源
JOURNAL OF PEDIATRICS | 2016年 / 169卷
基金
英国医学研究理事会;
关键词
INTELLECTUAL DISABILITY; WESTERN-AUSTRALIA; LIFE EXPECTANCY; MORTALITY; CHILDREN; INFANTS; TRENDS; PREVALENCE; PEOPLE; BORN;
D O I
10.1016/j.jpeds.2015.10.083
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To calculate the survival of people with Down syndrome over the past 60 years and the influence of major perinatal factors by using linked population-based data. Study design A data linkage between 2 Western Australian (WA) data sets (the Register for Developmental Anomalies and the Intellectual Disability Exploring Answers database) was used to identify 772 children born with Down syndrome in WA from 1980-2010. Perinatal and mortality data were extracted from the WA Midwives Information System and WA death registrations and compared with the remaining WA population born during that same era. An additional 606 children with Down syndrome living in WA prior to 1980 were available from a disability services database and were used for predicting survival into adulthood. Results Overall, for cases born 1953-2010, 88% (95% CI 86%, 90%) survived to 5 years of age, 87% (95% CI 85%, 89%) to 10 years, and 83% (95% CI 80%, 85%) to 30 years. Children live-born with Down syndrome were significantly more likely (all P > .001) to have mothers older than 35 years (32.7% vs 13.4%), a gestational age less than 37 weeks (23.8% vs 7.9%), a cesarean delivery (28.9% vs 23.0%), and a birth weight less than 2500 g (20.4% vs 6.1%). Down syndrome survival was reduced in the presence of a cardiovascular defect, younger gestational age, low birth weight, or earlier birth years. Conclusions Improved survival for children born with Down syndrome over the last 60 years has occurred incrementally, but disparities still exist for children who are preterm or have low birth weight.
引用
收藏
页码:214 / +
页数:8
相关论文
共 50 条
  • [41] Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
    Cohen, Jonathon B.
    McBride, Ali
    Geyer, Susan
    Bingman, Anissa
    Elder, Patrick
    Blum, William
    Klisovic, Rebecca
    Penza, Sam
    Andritsos, Leslie A.
    Benson, Don M.
    Efebera, Yvonne
    Hofineister, Craig C.
    Garzon, Ramiro
    Marcucci, Guido
    Devine, Steven M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S320 - S321
  • [42] Impact of lifestyle risk factors on admission to nursing home care: a cohort study of 127 108 people aged 60 years and over
    Gibson, Alice A.
    Gale, Joanne
    Stamatakis, Emmanuel
    Lindley, Richard, I
    Fontana, Luigi
    Cistulli, Peter A.
    Nassar, Natasha
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2023, 77 (11) : 744 - 751
  • [43] Assessment of Physical Fitness and Risk Factors for the Occurrence of the Frailty Syndrome among Social Welfare Homes' Residents over 60 Years of Age in Poland
    Kaczorowska, Antonina
    Szwamel, Katarzyna
    Fortuna, Malgorzata
    Mroczek, Agata
    Lepsy, Ewelina
    Katan, Aleksandra
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (12)
  • [44] Trends and Predictive Factors for Outcome of Relapsed Acute Myeloid Leukemia After Allogeneic Hematopoeitic Cell Transplant: Improved Survival for Young Patients in Recent Years
    Bazarbachi, Ali
    Labopin, Myriam
    Beelen, Dietrich
    Blau, Igor Wolfgang
    Potter, Victoria
    Niittyvuopio, Riitta
    Socie, Gerard
    Blaise, Didier
    Sanz, Jaime
    Ciceri, Fabio
    Spyridonidis, Alexandros
    Bug, Gesine
    Esteve, Jordi
    Savani, Bipin N.
    Schmid, Christoph
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 24 - 25
  • [45] RESPONSE AND SURVIVAL IMPROVEMENT WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: DIFFERENT INDUCTION THERAPY IMPACT OVER THE LAST 30 YEARS
    Mateos Perez, Jose Miguel
    Fernandez-Aviles, Francesc
    Fernandez de larrea, Carlos
    Teresa Cibeira, Maria
    Tovar, Natalia
    Martinez, Carmen
    Gerardo Rodrigez-Lobato, Luis
    Suarez-Lledo, Maria
    Queralt Salas, Maria
    Rovira, Montserrat
    Blade, Joan
    Rosinol, Laura
    BONE MARROW TRANSPLANTATION, 2024, 59 : 515 - 516
  • [46] Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
    Bazarbachi, Ali
    Schmid, Christoph
    Labopin, Myriam
    Beelen, Dietrich
    Blau, Igor Wolfgang
    Potter, Victoria
    Niittyvuopio, Riitta
    Socie, Gerard
    Blaise, Didier
    Sanz, Jaime
    Ciceri, Fabio
    Abou Dalle, Iman
    Spyridonidis, Alexandros
    Bug, Gesine
    Esteve, Jordi
    Savani, Bipin N.
    Nagler, Arnon
    Mohty, Mohamad
    CLINICAL CANCER RESEARCH, 2020, 26 (24) : 6475 - 6482
  • [47] THE IMPACT OF AGEING FOR PEOPLE WITH DOWN SYNDROME OVER THE AGE OF 40-YEARS LIVING IN IRELAND. A 10-YEAR LONGITUDINAL FOLLOW-UP
    Reilly, E.
    McCarron, M.
    McCallion, P.
    Carroll, R.
    Burke, E.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 640 - 640
  • [48] Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting
    Falchero, Lionel
    Meyer, Nicolas
    Molinier, Olivier
    Al Freijat, Faraj
    Pegliasco, Herve
    Lecuyer, Emmanuelle
    Stoven, Luc
    Belmont, Laure
    Loutski, Sandrine
    Maincent, Cecile
    Blanchet-Legens, Anne-Sophie
    Mairovitz, Alexa
    Meniai, Fatima
    Hominal, Stephane
    Letierce, Alexia
    Morel, Hugues
    Debieuvre, Didier
    EUROPEAN JOURNAL OF CANCER, 2024, 210
  • [49] Comparison of Time Trends of Cardiovascular Disease Risk Factors and Framingham Risk Score Between Patients With and Without Acute Coronary Syndrome Undergoing Percutaneous Intervention Over the Last 17 Years: From the Mayo Clinic Percutaneous Coronary Intervention Registry
    Lee, Moo-Sik
    Flammer, Andreas J.
    Li, Jing
    Lennon, Ryan J.
    Delacroix, Sinny
    Kim, Hyunsoo
    Lerman, Amir
    CLINICAL CARDIOLOGY, 2015, 38 (12) : 747 - 756
  • [50] Importance of Achieving Complete Remission (CR) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults Age ≥60 Years: Analysis of Risk Factors for Early Mortality and Re-Induction, and Impact of Quality of Response on Overall Survival (OS) in the ECOG-ACRIN E2906 Randomized Trial
    Foran, James M.
    Sun, Zhuoxin
    Claxton, David F.
    Lazarus, Hillard M.
    Thomas, Mary L.
    Melnick, Ari
    Levine, Ross L.
    Paietta, Elisabeth
    Arber, Daniel A.
    Zhang, Yanming
    Rowe, Jacob M.
    Godwin, John E.
    Altman, Jessica K.
    Luger, Selina
    Al-Kali, Aref
    Zheng, Hong
    Pratz, Keith W.
    Broun, E. Randolph
    Powell, Bayard L.
    O'Dwyer, Kristen
    Litzow, Mark
    Tallman, Martin S.
    BLOOD, 2016, 128 (22)